XPO1 and B-cell chronic lymphocytic leukemia: Investigating mechanisms behind the genetic and clinical heterogeneity of CLL, genomic studies have identified a number of recurrent somatic mutations affecting several critical regulatory proteins, including, among others, those affecting the nuclear export protein Exportin-1 (XPO1; also known as Chromosome Region Maintenance 1, CRM1) [22–24].